Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.
Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.
Reuters NewMedia - Monday June 21, 1999
Merck said in a statement clinical tests show the drug, with the active ingredient efavirenz, may be the most important addition to HIV/AIDS treatment since 1996 when protein inhibitors were introduced.
Stocrin is the first drug for treatment of HIV/AIDS which can be used daily in combination with other antiretroviral drugs.
About 150 patients in Sweden are being treated with a combination of substances including Stocrin and for many it has had life-saving significance, the statement said.
The simple dosage is an important factor for HIV/AIDS patients who have complex medication procedures.
"Stocrin has shown to be a valuble addition in our arsenal of HIV drugs. Especially attractive is that the number of capsules per day is low, three, and that this needs to be taken only once per day," said Anders Sonnerborg, virology professor at Stockholm's Huddinge hospital.
"At the same time the drug has at least the same anti-virus effect as protein inhibitors."
Merck Sharp and Dohme also researched and developed protein inhibitors Crixivan.
990621
RE990611
Copyright © 1999 - Reuters, Ltd. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Contact Reuters.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .